Nephros Inc (NEPH) income statement
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)
Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –
Nephros Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 61.3%
- Operating margin
- 7.9%
- Net margin
- 8.4%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 4.07
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 140.5%
Valuation
- P/E ratio
- 18.1
- Price to sales
- 1.51
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?